Q3 2026 Holdings
Filed 2026-10-16 | 7 holdings | $175.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Kestra MED Technologies LTD(KMTS) | SHS | G52441105 | $77.2M | 2,728,679 | 43.9% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $40.0M | 1,591,917 | 22.8% |
| Avalyn Pharmaceuticals Inc(AVLN) | COM SHS | 05348Y105 | $26.5M | 929,824 | 15.1% |
| Agomab Therapeutics NV(AGMB) | SPONSORED ADS | 00860C102 | $17.1M | 1,538,702 | 9.7% |
| Inventiva SA(IVA) | ADS | 46124U107 | $13.4M | 3,633,181 | 7.6% |
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $804.2K | 97,362 | 0.5% |
| Nyxoah S A(NYXH) | SHS | B6S7WD106 | $720.4K | 522,057 | 0.4% |